Skip to main content
OpenTrials

Clinical trial condition

Severe combined immunodeficiency due to adenosine deaminase deficiency

Explore clinical trials studying Severe combined immunodeficiency due to adenosine deaminase deficiency. Study availability and eligibility vary by location and protocol.

20 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Severe combined immunodeficiency due to adenosine deaminase deficiency trial results

Enrolling by Invitation

An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID

NCT04049084

Conditions
Adenosine Deaminase Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, +10 more
Locations
  • Mattel Children's Hospital UCLA/Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCL Great Ormond Street Institute of Child Health London, United Kingdom
View Trial Details
Enrolling by Invitation

Natural History Study of SCID Disorders

NCT01186913

Conditions
ADA SCID, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, +17 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
View all 44 locations
View Trial Details
Completed

Registry Study of Revcovi Treatment in Patients With ADA-SCID

NCT03878069

Conditions
Adenosine Deaminase Severe Combined Immunodeficiency, Severe combined immunodeficiency due to adenosine deaminase deficiency
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Allergy & Asthma Medical Group and Research Center, A P.C. San Diego, California, United States
  • UCSF - University of California San Francisco, California, United States
  • Children's National Washington D.C., District of Columbia, United States
View all 14 locations
View Trial Details

Related conditions